Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPS27AP16 is a processed pseudogene located on human chromosome 16q21 and is designated by Gene ID 643358[2]. It does not contain coding exons and is classified as a non-functional genomic copy derived from the ribosomal protein S27a (RPS27A) gene[2][7]. Pseudogenes such as RPS27AP16 generally do not encode functional proteins and have historically been considered "genomic fossils." Some pseudogenes of RPS27A, like RPS27AP5, may express protein variants in rare circumstances[1], but there is currently no evidence that RPS27AP16 encodes any functional or regulatory product. Consequently, it is not associated with pharmacologically relevant biological functions, disease roles, or drug interactions, and is not considered a therapeutic target[2][7]. Its alternative names and synonyms include RPS27A_8_1488 and ribosomal protein S27a pseudogene 16[2][7]. RPS27AP16 is a non-coding pseudogene derived from the ribosomal protein S27a gene, with no active protein product or established therapeutic significance[2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RPS27A pseudogene 16 (RPS27AP16).